TRIM66 is involved in the regulation of GSK-3β phosphorylation and β-catenin expression and acts as an oncoprotein in HCC by activating the GSK-3β-dependent Wnt/β-catenin signaling (Fan et al., 2019). Here, GSK3B is linked to hepatocellular carcinoma.